通过估计特定人群剂量-毒性曲线之间的相似性,为剂量确定试验的借贷过程提供信息.
Dario Zocholl1, Heiko Götte2, Christina Habermehl2
1Institute for Medical Biometry, Informatics and Epidemiology, Faculty of Medicine, University of Bonn, Bonn, Germany.
Pharmaceutical statistics
|December 19, 2025
概括
这项研究引入了一种用于儿科剂量检测试验的新方法,经验性地确定从成人试验中借来的数据. 这种方法通过分析化合物相似性来提高小种群的精度,改进了贝叶斯方法.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 制药指标 (Pharmacometrics) 是一个指标.
背景情况:
- 像儿科一样,在小人群中进行剂量检测试验存在重大挑战.
- 目前的贝叶斯方法从成年人试验中借鉴信息,但借鉴的程度是主观的.
- 现有的方法缺乏客观的标准来确定最佳程度的数据借用.
研究的目的:
- 提出一种实证方法来确定剂量检测试验中借鉴信息的程度.
- 将这种方法应用于儿科剂量确定,利用类似化合物的元分析.
- 评估不同统计模型与拟议的借贷方法相结合的性能.
主要方法:
- 对生物相似化合物的剂量毒性曲线进行了元分析.
- 应用了两个统计建模方法,ExNex和层次模型.
- 这种相似程度被转化为差异通胀或强大的混合先前分布.
主要成果:
- 混合先验显示出有希望的结果,特别是在更多的化合物 (20).
- 差异通胀模型需要进一步调整,并且表现出不那么稳健.
- 使用较少的化合物 (3或7个),拟议的方法的性能与忽视外部数据的强大先验方法相比相当或略高.
结论:
- 拟议的经验方法提供了一种数据驱动的方法,用于优化剂量检测试验中的信息借用.
- 混合物先验特别有效,当有来自多个类似化合物的外部数据可用时.
- 这种方法的实际采用可能取决于获得外部化合物数据所需的资源.
更多相关视频
相关概念视频
Dosage Regimens: Partial Pharmacokinetic Parameters
133
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
133
Dose Size and Dosing Frequency: Determination Methods
250
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
250
Analysis of Population Pharmacokinetic Data
653
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
653
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
198
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
198
Dosage Regimens: Designs and Approaches
239
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
239
Dosage Regimen: Individualization
151
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
151


